Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Military Medicine
|
December 1, 1999
Development of a core curriculum in professional growth: practice management military model
R P Perez, F B Brown, E R Salminen, et al.
Biochemical Pharmacology
|
July 12, 1996
Increased DT-diaphorase expression and cross-resistance to mitomycin C in a series of cisplatin-resistant human ovarian cancer cell lines
P J O'Dwyer, R P Perez, K S Yao, et al.
International Journal of Cancer
|
May 10, 1991
Comparative cytotoxicity of CI-973, cisplatin, carboplatin and tetraplatin in human ovarian carcinoma cell lines
R P Perez, P J O'Dwyer, L M Handel, et al.
Gynecologic Oncology
|
September 1, 1995
Determinants of cisplatin sensitivity in normal versus spontaneously transformed rat ovarian surface epithelial cells
R P Perez, S W Johnson, L M Handel, et al.
Investigational New Drugs
|
July 1, 1992
Phase II study of amonafide in advanced and recurrent sarcoma patients
R P Perez, S L Nash, R F Ozols, et al.
The American Journal of Medicine
|
June 1, 1990
AIDS and Chagas' disease with central nervous system tumor-like lesion
M Del Castillo, G Mendoza, J Oviedo, et al.
Cancer Research
|
August 15, 1993
Transformation of rat ovarian epithelial and Rat-1 fibroblast cell lines by RAST24 does not influence cisplatin sensitivity
R P Perez, K Hamaguchi, P A Tracey, et al.
Seminars in Oncology
|
December 1, 1996
Early phase studies with paclitaxel/low-dose carboplatin in patients with solid tumors
P J Creaven, D Raghavan, R P Perez, et al.
Biochemical Pharmacology
|
February 11, 1994
Role of platinum-DNA adduct formation and removal in cisplatin resistance in human ovarian cancer cell lines
S W Johnson, R P Perez, A K Godwin, et al.
Cancer Research
|
February 1, 1994
Phase I and pharmacokinetic study of ormaplatin (tetraplatin, NSC 363812) administered on a day 1 and day 8 schedule
R J Schilder, F P LaCreta, R P Perez, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Military Medicine
|
December 1, 1999
Development of a core curriculum in professional growth: practice management military model
R P Perez, F B Brown, E R Salminen, et al.
Biochemical Pharmacology
|
July 12, 1996
Increased DT-diaphorase expression and cross-resistance to mitomycin C in a series of cisplatin-resistant human ovarian cancer cell lines
P J O'Dwyer, R P Perez, K S Yao, et al.
International Journal of Cancer
|
May 10, 1991
Comparative cytotoxicity of CI-973, cisplatin, carboplatin and tetraplatin in human ovarian carcinoma cell lines
R P Perez, P J O'Dwyer, L M Handel, et al.
Gynecologic Oncology
|
September 1, 1995
Determinants of cisplatin sensitivity in normal versus spontaneously transformed rat ovarian surface epithelial cells
R P Perez, S W Johnson, L M Handel, et al.
Investigational New Drugs
|
July 1, 1992
Phase II study of amonafide in advanced and recurrent sarcoma patients
R P Perez, S L Nash, R F Ozols, et al.
The American Journal of Medicine
|
June 1, 1990
AIDS and Chagas' disease with central nervous system tumor-like lesion
M Del Castillo, G Mendoza, J Oviedo, et al.
Cancer Research
|
August 15, 1993
Transformation of rat ovarian epithelial and Rat-1 fibroblast cell lines by RAST24 does not influence cisplatin sensitivity
R P Perez, K Hamaguchi, P A Tracey, et al.
Seminars in Oncology
|
December 1, 1996
Early phase studies with paclitaxel/low-dose carboplatin in patients with solid tumors
P J Creaven, D Raghavan, R P Perez, et al.
Biochemical Pharmacology
|
February 11, 1994
Role of platinum-DNA adduct formation and removal in cisplatin resistance in human ovarian cancer cell lines
S W Johnson, R P Perez, A K Godwin, et al.
Cancer Research
|
February 1, 1994
Phase I and pharmacokinetic study of ormaplatin (tetraplatin, NSC 363812) administered on a day 1 and day 8 schedule
R J Schilder, F P LaCreta, R P Perez, et al.
Page
of 4